Dr Husain on Developments in ALK+ NSCLC
Hatim Husain, MD, discusses developments in ALK-positive non–small cell lung cancer.
Source: onclive.com
Hatim Husain News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hatim Husain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hatim Husain Today - Breaking & Trending Today
Can Abemaciclib Overcome Osimertinib Resistance in EGFR-Mutant NSCLC?
Researchers are conducting a phase 2 trial to determine if adding abemaciclib to osimertinib can overcome resistance to osimertinib in EGFR-mutant non-small cell lung cancer.
Source: cancertherapyadvisor.com
BillionToOne launches oncology liquid biopsy products for research use & announces clinical research collaboration with UCSD
/PRNewswire/ -- BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to...
Source: prnewswire.com